BU-NOT-SET

CONTACT US
A Versatile One-Pot Procedure for the Synthesis of 5-Aryl-6H- 1,3,4-thiadiazine-2-amines from Aromatic Ketones
  • Drug substance
Eyes
Insight
Insight
  • Industry trends
Recipharm on the impact of COVID-19 on API supply
Insight
  • Drug product
The role of excipient selection in the development of orally disintegrating tablets
Insight
  • Industry trends
The outlook for a year of change
Insight
  • Drug product
Can oral solid dose keep its place as the leading dosage form?
Insight
  • Drug substance
Relocating API supply to avoid over-reliance
Case study
  • Drug product
Modified release fixed dose combination product with two poorly soluble drug substances
Insight
  • Drug product
Patient centricity during drug development and commercialisation
Insight
  • Drug product
10 considerations to kick-start your drug development journey
Insight
  • Drug product
Guidance for start-ups on drug development